Annual D&A
$5.04 B
+$124.68 M+2.53%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual depreciation & amortization is currently $5.04 billion, with the most recent change of +$124.68 million (+2.53%) on 31 March 2024. During the last 3 years, it has fallen by -$234.54 million (-4.44%). TAK annual D&A is now -6.05% below its all-time high of $5.37 billion, reached on 31 March 2020.TAK Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.36 B
+$123.67 M+10.03%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly depreciation & amortization is currently $1.36 billion, with the most recent change of +$123.67 million (+10.03%) on 01 September 2024. Over the past year, it has increased by +$154.45 million (+12.85%). TAK quarterly D&A is now -3.38% below its all-time high of $1.40 billion, reached on 31 March 2022.TAK Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$5.18 B
+$154.45 M+3.07%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited TTM depreciation & amortization is currently $5.18 billion, with the most recent change of +$154.45 million (+3.07%) on 01 September 2024. Over the past year, it has increased by +$170.92 million (+3.41%). TAK TTM D&A is now -3.49% below its all-time high of $5.37 billion, reached on 31 March 2020.TAK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | +12.8% | +3.4% |
| 3 y3 years | -4.4% | +6.8% | -0.6% |
| 5 y5 years | +125.8% | -0.5% | +21.4% |
TAK Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.4% | +2.5% | -3.4% | +19.1% | -0.6% | +5.3% |
| 5 y | 5 years | -6.0% | +125.8% | -3.4% | +19.1% | -3.5% | +21.4% |
| alltime | all time | -6.0% | +2115.4% | -3.4% | +481.1% | -3.5% | +1565.7% |
Takeda Pharmaceutical Company Limited Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.36 B(+10.0%) | $5.18 B(+3.1%) |
| June 2024 | - | $1.23 B(-10.6%) | $5.03 B(-0.3%) |
| Mar 2024 | $5.04 B(+2.5%) | $1.38 B(+13.6%) | $5.04 B(+0.5%) |
| Dec 2023 | - | $1.21 B(+0.9%) | $5.02 B(+0.1%) |
| Sept 2023 | - | $1.20 B(-3.8%) | $5.01 B(+1.3%) |
| June 2023 | - | $1.25 B(-7.6%) | $4.95 B(+0.6%) |
| Mar 2023 | $4.92 B(-5.3%) | $1.35 B(+12.0%) | $4.92 B(-1.0%) |
| Dec 2022 | - | $1.21 B(+6.0%) | $4.97 B(-0.1%) |
| Sept 2022 | - | $1.14 B(-6.8%) | $4.98 B(-2.6%) |
| June 2022 | - | $1.22 B(-13.0%) | $5.11 B(-1.6%) |
| Mar 2022 | $5.19 B(-1.6%) | $1.40 B(+15.7%) | $5.19 B(+2.9%) |
| Dec 2021 | - | $1.21 B(-4.5%) | $5.05 B(-3.2%) |
| Sept 2021 | - | $1.27 B(-2.7%) | $5.21 B(-1.1%) |
| June 2021 | - | $1.31 B(+4.0%) | $5.27 B(-0.2%) |
| Mar 2021 | $5.28 B(-1.7%) | $1.26 B(-9.1%) | $5.28 B(-1.6%) |
| Dec 2020 | - | $1.38 B(+4.0%) | $5.37 B(+1.6%) |
| Sept 2020 | - | $1.33 B(+0.9%) | $5.28 B(-0.7%) |
| June 2020 | - | $1.32 B(-2.0%) | $5.32 B(-1.0%) |
| Mar 2020 | $5.37 B(+140.4%) | $1.34 B(+3.7%) | $5.37 B(+2.7%) |
| Dec 2019 | - | $1.29 B(-5.1%) | $5.23 B(+22.6%) |
| Sept 2019 | - | $1.36 B(-0.3%) | $4.27 B(+31.3%) |
| June 2019 | - | $1.37 B(+13.8%) | $3.25 B(+45.4%) |
| Mar 2019 | $2.23 B(+35.9%) | $1.20 B(+262.2%) | $2.23 B(+58.2%) |
| Dec 2018 | - | $332.05 M(-4.0%) | $1.41 B(-5.9%) |
| Sept 2018 | - | $346.02 M(-2.1%) | $1.50 B(-5.2%) |
| June 2018 | - | $353.56 M(-7.0%) | $1.58 B(-3.6%) |
| Mar 2018 | $1.64 B(+3.7%) | $380.30 M(-9.7%) | $1.64 B(+9.8%) |
| Dec 2017 | - | $421.23 M(-1.8%) | $1.50 B(+7.8%) |
| Sept 2017 | - | $428.96 M(+3.8%) | $1.39 B(-12.8%) |
| June 2017 | - | $413.29 M(+77.0%) | $1.59 B(+0.5%) |
| Mar 2017 | $1.59 B | $233.48 M(-25.4%) | $1.59 B(-11.9%) |
| Dec 2016 | - | $313.14 M(-50.5%) | $1.80 B(-5.6%) |
| Sept 2016 | - | $633.00 M(+56.1%) | $1.91 B(+15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $405.57 M(-9.5%) | $1.65 B(+0.1%) |
| Mar 2016 | $1.64 B(-31.1%) | $448.05 M(+6.9%) | $1.64 B(-18.0%) |
| Dec 2015 | - | $419.22 M(+12.1%) | $2.01 B(-9.8%) |
| Sept 2015 | - | $373.99 M(-7.3%) | $2.22 B(-4.3%) |
| June 2015 | - | $403.60 M(-50.1%) | $2.32 B(-2.7%) |
| Mar 2015 | $2.39 B(+10.8%) | $808.72 M(+26.8%) | $2.39 B(+1.7%) |
| Dec 2014 | - | $637.62 M(+34.9%) | $2.35 B(+8.5%) |
| Sept 2014 | - | $472.71 M(+1.2%) | $2.16 B(+0.3%) |
| June 2014 | - | $467.23 M(-39.3%) | $2.16 B(+0.1%) |
| Mar 2014 | $2.15 B(-28.0%) | $769.27 M(+69.3%) | $2.15 B(+55.6%) |
| Dec 2013 | - | $454.35 M(-2.5%) | $1.38 B(+48.8%) |
| Sept 2013 | - | $466.02 M(+0.4%) | $930.41 M(+100.4%) |
| June 2013 | - | $464.39 M(+46.4%) | $464.39 M(-62.5%) |
| Mar 2013 | $2.99 B(+57.2%) | - | - |
| Mar 2012 | $1.90 B(+53.5%) | - | - |
| Mar 2011 | $1.24 B(+0.2%) | $317.18 M(-2.9%) | $1.24 B(+5.1%) |
| Dec 2010 | - | $326.62 M(+4.0%) | $1.18 B(-1.0%) |
| Sept 2010 | - | $314.00 M(+11.5%) | $1.19 B(-1.4%) |
| June 2010 | - | $281.67 M(+9.4%) | $1.21 B(-2.4%) |
| Mar 2010 | $1.24 B(+4.2%) | $257.43 M(-23.9%) | $1.24 B(+26.3%) |
| Dec 2009 | - | $338.22 M(+2.3%) | $980.10 M(+52.7%) |
| Sept 2009 | - | $330.75 M(+6.3%) | $641.88 M(+106.3%) |
| June 2009 | - | $311.13 M | $311.13 M |
| Mar 2009 | $1.19 B(+327.0%) | - | - |
| Mar 2008 | $278.09 M(+12.8%) | - | - |
| Mar 2007 | $246.53 M(-3.0%) | - | - |
| Mar 2006 | $254.08 M(-12.7%) | - | - |
| Mar 2005 | $290.98 M(+16.8%) | - | - |
| Mar 2004 | $249.16 M(+1.2%) | - | - |
| Mar 2003 | $246.14 M(+8.1%) | - | - |
| Mar 2002 | $227.72 M(-25.2%) | - | - |
| Mar 2001 | $304.53 M(+1.2%) | - | - |
| Mar 2000 | $300.85 M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual depreciation & amortization?
- What is the all time high annual D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual D&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly D&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM D&A year-on-year change?
What is Takeda Pharmaceutical Company Limited annual depreciation & amortization?
The current annual D&A of TAK is $5.04 B
What is the all time high annual D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual depreciation & amortization is $5.37 B
What is Takeda Pharmaceutical Company Limited annual D&A year-on-year change?
Over the past year, TAK annual depreciation & amortization has changed by +$124.68 M (+2.53%)
What is Takeda Pharmaceutical Company Limited quarterly depreciation & amortization?
The current quarterly D&A of TAK is $1.36 B
What is the all time high quarterly D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly depreciation & amortization is $1.40 B
What is Takeda Pharmaceutical Company Limited quarterly D&A year-on-year change?
Over the past year, TAK quarterly depreciation & amortization has changed by +$154.45 M (+12.85%)
What is Takeda Pharmaceutical Company Limited TTM depreciation & amortization?
The current TTM D&A of TAK is $5.18 B
What is the all time high TTM D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM depreciation & amortization is $5.37 B
What is Takeda Pharmaceutical Company Limited TTM D&A year-on-year change?
Over the past year, TAK TTM depreciation & amortization has changed by +$170.92 M (+3.41%)